Metro Health & Beauty Limited 31/01/2025 iXBRL

Company registration number: 06076683

Metro Health & Beauty Limited

Unaudited filleted abridged financial statements

31 January 2025

Metro Health & Beauty Limited

Contents

Directors and other information

Abridged statement of financial position

Notes to the financial statements

Metro Health & Beauty Limited

Directors and other information


	Director	Mr Rajeshwar Sandhan


	Secretary	Mrs Reena Sandhan


	Company number	06076683


	Registered office	Unit 4,
		89 Manor Farm Road
		Wembley
		HA0 1BA




	Bankers	Natwest Bank Plc
		P Box No420
		88 Cromwell Road
		SW7 4EW

Metro Health & Beauty Limited

Abridged statement of financial position

31 January 2025

		2025		2024
	Note	£	£	£	£

Fixed assets
Tangible assets	5	17,601		21,737
		_______		_______
			17,601		21,737

Current assets
Stocks		198,405		212,875
Debtors		343,517		247,623
Cash at bank and in hand		1,115,355		712,618
		_______		_______
		1,657,277		1,173,116
Creditors: amounts falling due
within one year		( 313,894)		( 169,572)
		_______		_______
Net current assets			1,343,383		1,003,544
			_______		_______
Total assets less current liabilities			1,360,984		1,025,281


Provisions for liabilities			( 3,960)		( 4,891)

			_______		_______
Net assets			1,357,024		1,020,390
			_______		_______

Capital and reserves
Called up share capital	6		20		20
Profit and loss account			1,357,004		1,020,370
			_______		_______
Shareholders funds			1,357,024		1,020,390
			_______		_______

For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.

All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the current year ending 31 January 2025 in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements were approved by the board of directors and authorised for issue on 30 October 2025 , and are signed on behalf of the board by:

Mr Rajeshwar Sandhan

Director

Company registration number: 06076683

Metro Health & Beauty Limited

Statement of changes in equity

Year ended 31 January 2025

	Called up share capital	Profit and loss account	Total
	£	£	£


At 1 February 2023	20	879,132	879,152

Profit for the year		201,238	201,238
	_______	_______	_______
Total comprehensive income for the year	-	201,238	201,238

Dividends paid and payable		( 60,000)	( 60,000)
	_______	_______	_______
Total investments by and distributions to owners	-	( 60,000)	( 60,000)

	_______	_______	_______
At 31 January 2024 and 1 February 2024	20	1,020,370	1,020,390

Profit for the year		384,634	384,634
	_______	_______	_______
Total comprehensive income for the year	-	384,634	384,634

Dividends paid and payable		( 48,000)	( 48,000)
	_______	_______	_______
Total investments by and distributions to owners	-	( 48,000)	( 48,000)

	_______	_______	_______
At 31 January 2025	20	1,357,004	1,357,024
	_______	_______	_______

Metro Health & Beauty Limited

Notes to the financial statements

Year ended 31 January 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 4,, 89 Manor Farm Road, Wembley, HA0 1BA.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

In preparing the financial statements, the director has taken into account all the information that could reasonably be expected to be available together with his continued support. At the time of approving the financial statements, the director has reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and meet its liabilities as they fall due. The director continues to adopt the going concern basis of accounting in preparing the financial statements on the basis that there are no material uncertainties related to events and conditions, that may cast doubt on the ability of the company to continue as a going concern.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:


Plant and machinery	-	20 %	reducing balance
Fittings fixtures and equipment	-	20 %	reducing balance
Motor vehicles	-	25 %	reducing balance

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 7 (2024: 7 ).

5. Tangible assets


		£
	Cost
	At 1 February 2024	69,579
	Additions	430
		_______
	At 31 January 2025	70,009
		_______
	Depreciation
	At 1 February 2024	47,842
	Charge for the year	4,566
		_______
	At 31 January 2025	52,408
		_______
	Carrying amount
	At 31 January 2025	17,601
		_______
	At 31 January 2024	21,737
		_______

6. Called up share capital

Issued, called up and fully paid

	2025		2024
	No	£	No	£
Ordinary shares of £ 1.00 each	10	10	10	10
Ordinary B shares of £ 1.00 each	10	10	10	10
	_______	_______	_______	_______
	20	20	20	20
	_______	_______	_______	_______

7. Directors advances, credits and guarantees

	During the year the director entered into the following advances and credits with the company:

2025
		Balance brought forward	Advances /(credits) to the director	Amounts repaid	Balance o/standing
		£	£	£	£
	Mr Rajeshwar Sandhan	-	( 4,265)	4,265	-
		_______	_______	_______	_______

2024
		Balance brought forward	Advances /(credits) to the director	Amounts repaid	Balance o/standing
		£	£	£	£
	Mr Rajeshwar Sandhan	-	( 7,175)	7,175	-
		_______	_______	_______	_______

8. Controlling party

During the year the company was controlled by Mr Rajeshwar Sandhan .